Anlotinib treatment in locally advanced or metastatic medullary thyroid carcinoma: A multicenter, randomized, double-blind, placebo-controlled phase IIB trial.

Dapeng Li, Ming Gao, Minghua Ge et al.|Journal of Clinical Oncology|2019

Cited by 14